Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 901-904

  Borrmann, Steffen ^a,b,d   Adegnika, Ayola A ^a,b   Missinou, Michel A ^a,b   Binder, Ronald K ^a   Issifou, Saadou ^a,b   Schindler, Andreas ^a   Matsiegui, Pierre Blaise ^a   Kun, Jürgen F J ^b   Krishna, Sanjeev ^c   Lell, Bertrand ^a,b   Kremsner, Peter G ^a,b  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d Sektion Humanparasitologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ENDEMIC DISEASE; FEMALE; FEVER; GABON; HEADACHE; HUMAN; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; SHORT COURSE THERAPY; SIDE EFFECT; TABLET; VERTIGO; VOMITING;

ADOLESCENT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; FEMALE; GABON; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES; TREATMENT OUTCOME;

EID: 0037417026     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.901-904.2003     Document Type: Article

References (27)

1. Adjuik, M., P. Agnamey, A. Babiker, S. Borrmann, P. Brasseur, M. Cisse, F. Cobelens, S. Diallo, J. F. Faucher, P. Garner, S. Gikunda, P. G. Kremsner, S. Krishna, B. Lell, M. Loolpapit, P.-B. Matsiegui, M. A. Missinou, J. Mwanza, F. Ntoumi, P. Olliaro, P. Osimbo, P. Rezbach, E. Some, and W. R. Taylor. 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359:1365-1372.
2. Alin, M. H., C. M. Kihamia, A. Bjorkman, B. A. Bwijo, Z. Premji, G. J. Mtey, and M. Ashton. 1995. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine. Am. J. Trop. Med. Hyg. 53:639-645.
3. Basco, L. K., J. Bickii, and P. Ringwald. 1998. In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Antimicrob. Agents Chemother. 42:2347-2351.
4. Brockman, A., R. N. Price, M. van Vugt, D. G. Heppner, D. Walsh, P. Sookto, T. Wimonwattrawatee, S. Looareesuwan, N. J. White, and F. Nosten. 2000. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans. R. Soc. Trop. Med. Hyg. 94:537-544.
5. Bunnag, D., C. Viravan, S. Looareesuwan, J. Karbwang, and T. Harinasuta. 1991. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J. Trop. Med. Public Health 22:380-385.
6. Ezedinachi, E. 1996. In vivo efficacy of chloroquine, halofantrine, pyrimethamine-sulfadoxine and qinghaosu (artesunate) in the treatment of malaria in Calabar, Nigeria. Cent. Afr. J. Med. 42:109-111.
7. Halpaap, B., M. Ndjave, M. Paris, A. Benakis, and P. G. Kremsner. 1998. Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories. Am. J. Trop. Med. Hyg. 58:365-368.
8. Hassan, A. M., M. Ashton, C. M. Kihamia, G. J. Mtey, and A. Bjorkman. 1996. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg. 90:61-65.
9. Kun, J. F., R. J. Schmidt-Ott, L. G. Lehman, B. Lell, D. Luckner, B. Greve, P. Matousek, and P. G. Kremsner. 1998. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Trans. R. Soc. Trop. Med. Hyg. 92:110-114.
10. Li, G. Q., X. B. Guo, L. C. Fu, H. X. Jian, and X. H. Wang. 1994. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1):S5-S6.
11. Looareesuwan, S., C. Viravan, S. Vanijanonta, P. Wilairatana, P. Suntharasamai, P. Charoenlarp, K. Arnold, D. Kyle, C. Canfield, and K. Webster. 1992. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339:821-824.
12. Marsh, K. 1998. Malaria disaster in Africa. Lancet 352:924.
13. Missinou, M. A., O. Dangelmaier, J. F. Kun, and P. G. Kremsner. 2000. Genetic diversity of Plasmodium falciparum infections in one family in Lambarene. Trans. R. Soc. Trop. Med. Hyg. 94:376.
14. Molineaux, L., H. H. Diebner, M. Eichner, W. E. Collins, G. M. Jeffery, and K. Dietz. 2001. Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology 122:379-391.
15. Mordmüller, B., W. Graninger, and P. G. Kremsner. 1998. Malaria therapy in the era of chloroquine resistance. Wien. Klin. Wochenschr. 110:321-325.
16. Newton, P., Y. Suputtamongkol, P. Teja-Isavadharm, S. Pukrittayakamee, V. Navaratnam, I. Bates, and N. White. 2000. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria. Antimicrob. Agents Chemother. 44:972-977.
17. Nosten, F., C. Luxemburger, F. O. ter Kuile, C. Woodrow, J. P. Eh, T. Chongsuphajaisiddhi, and N. J. White. 1994. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 170:971-977.
18. Planche, T., S. Krishna, M. Kombila, K. Engel, J. F. Faucher, E. NgouMilama, and P. G. Kremsner. 2001. Comparison of methods for the rapid laboratory assessment of children with malaria. Am. J. Trop. Med. Hyg. 65:599-602.
19. Sahr, F., V. R. Willoughby, A. A. Gbakima, and M. J. Bockarie. 2001. Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports. Ann. Trop. Med. Parasitol. 95:445-449.
20. Sylla, E. H., J. F. Kun, and P. G. Kremsner. 2000. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Trans. R. Soc. Trop. Med. Hyg. 94:652-656.
21. Sylla, E. H., B. Lell, J. F. Kun, and P. G. Kremsner. 2001. Plasmodium falciparum transmission intensity and infection rates in children in Gabon. Parasitol. Res. 87:530-533.
22. Trape, J. F., G. Pison, M. P. Preziosi, C. Enel, L. A. Desgrees du Lou, V. Delaunay, B. Samb, E. Lagarde, J. F. Molez, and F. Simondon. 1998. Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. Ser. III 321:689-697.
23. von Seidlein, L., P. Milligan, M. Pinder, K. Bojang, C. Anyalebechi, R. Gosling, R. Coleman, J. I. Ude, A. Sadiq, M. Duraisingh, D. Warhurst, A. Alloueche, G. Targett, K. McAdam, B. Greenwood, G. Walraven, P. Olliaro, and T. Doherty. 2000. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355:352-357.
24. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
25. White, N. J., and P. Olliaro. 1998. Artemisinin and derivatives in the treatment of uncomplicated malaria. Med. Trop. 58:54-56.
26. Wildling, E., S. Winkler, P. G. Kremsner, C. Brandts, L. Jenne, and W. H. Wernsdorfer. 1995. Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop. Med. Parasitol. 46:77-82.
27. World Health Organization. 1996. Assessment of therapeutic efficacy of antimalarial drugs. World Health Organization, Geneva, Switzerland.